Prevention of Sustained Ventricular Tachyarrhythmias in Patients with Implantable Cardioverter-Defibrillators—The PREVENT Study

被引：0

作者：

Dietmar Wietholt

Volker Kuehlkamp

Ekkhard Meisel

Ellen Hoffmann

Christoph Stellbrink

Joerg Neuzner

Karl Seidl

Peter Szigat

Juergen Potratz

机构：

[1] Emergency Hospital,Department of Internal Medicine/Cardiology

来源：

Journal of Interventional Cardiac Electrophysiology | 2003年 / 9卷

关键词：

tachyarrhythmias; preventive pacing; 'rate smoothing'; 'pause-prevention algorithms'; defibrillators;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: In patients with implantable cardioverter-defibrillators (ICDs), 25 to 45% of tachyarrhythmia episodes were initiated by short-long-short RR intervals.

引用

页码：383 / 389

页数：6

共 50 条

[31] Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death Too Little and Too Late?
Albert, Christine M.
Stevenson, William G.
CIRCULATION, 2013, 128 (16) : 1721 - 1723
[32] Prevention of Recurrent Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators-A Network Meta-analysis
Malik, Aaqib H.
Aronow, Wilbert S.
AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E469 - E480
[33] Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients
Al-Khatib, Sana M.
Thomas, Kevin L.
CIRCULATION, 2023, 148 (03) : 253 - 255
[34] Sprint Fidelis implantable cardioverter-defibrillators lead patient management and survival: Single center study
Grabowski, Marcin
Rokicki, Jakub K.
Gajda, Sylwia
Januszkiewicz, Lukasz
Cacko, Andrzej
Stolarz, Przemyslaw
Opolski, Grzegorz
CARDIOLOGY JOURNAL, 2017, 24 (03) : 259 - 265
[35] Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging
Kahaly, Omar Ray
Shafiei, Fereidoon
Hardebeck, Charles
Houmsse, Mahmoud
TEXAS HEART INSTITUTE JOURNAL, 2017, 44 (03): : 223 - 225
[36] Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators Results of a Prospective, Multinational Registry
Lampert, Rachel
Olshansky, Brian
Heidbuchel, Hein
Lawless, Christine
Saarel, Elizabeth
Ackerman, Michael
Calkins, Hugh
Estes, N. A. Mark
Link, Mark S.
Maron, Barry J.
Marcus, Frank
Scheinman, Melvin
Wilkoff, Bruce L.
Zipes, Douglas P.
Berul, Charles I.
Cheng, Alan
Law, Ian
Loomis, Michele
Barth, Cheryl
Brandt, Cynthia
Dziura, James
Li, Fangyong
Cannom, David
CIRCULATION, 2013, 127 (20) : 2021 - 2030
[37] Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: A Brief Review of the Current Landscape
Zheng, Henry C.
Afshar, Hamid
TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (06)
[38] Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature
Brilakis, ES
Friedman, PA
Maounis, TN
Rokas, SG
Shen, WK
Stamatelopoulos, SF
Cokkinos, DV
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (03) : 395 - 401
[39] Quality of Life and Quality of Evidence for Subcutaneous Versus Transvenous Implantable Cardioverter-Defibrillators
Caughron, Hope
Dhruva, Sanket S.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (11):
[40] Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Maron, Barry J.
Casey, Susan A.
Olivotto, Iacopo
Sherrid, Mark V.
Semsarian, Christopher
Autore, Camillo
Ahmed, Aisha
Boriani, Giuseppe
Francia, Pietro
Winters, Stephen L.
Giudici, Michael
Koulova, Anna
Garberich, Ross
Rowin, Ethan J.
Sears, Samuel F.
Maron, Martin S.
Spirito, Paolo
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (04)

← 1 2 3 4 5 →